Active ingredientCarboprostCat. No. P-C043-001CAS 35700-23-3Family · Pharmaceutical analytical standards
Carboprost
A synthetic analogue of prostaglandin F2 alpha, developed in the early 1970s: a methyl group at position 15 stops enzymes from inactivating it. It makes the uterus contract and is used mainly to stop bleeding after childbirth when other drugs are not enough. This family brings together the active ingredient, pharmacopoeial impurities and other impurities.
Did you know?Its total synthesis was published in 1974 by three chemists, Yankee, Axen and Bundy; it has to be stored in a refrigerator, between 2 and 8 °C.
Go to the active ingredient →Active ingredientCarboprostCat. No. P-C043-001CAS 35700-23-3
Active ingredientCarboprost TrometamolCat. No. P-C043-002CAS 58551-69-2
Pharmacopoeial impurityCarboprost Trometamol EP Impurity ACat. No. P-C043-003CAS 76498-29-8
Pharmacopoeial impurityCarboprost Trometamol EP Impurity BCat. No. P-C043-004CAS 35864-81-4
ImpurityCarboprost Impurity 1Cat. No. P-C043-005
ImpurityCarboprost Impurity 2Cat. No. P-C043-006
ImpurityCarboprost Impurity 3Cat. No. P-C043-007
ImpurityCarboprost Impurity 4Cat. No. P-C043-008
ImpurityCarboprost Impurity 5Cat. No. P-C043-009
ImpurityCarboprost Impurity 6Cat. No. P-C043-010
ImpurityCarboprost Trometamol Impurity ACat. No. P-C043-012No product matches your search.
EDQM standards 3
The official European Pharmacopoeia standards for this family.
Reference substanceCarboprost trometamol CRSEDQM code Y0000475Family CarboprostReference substanceCarboprost trometamol CRSEDQM code Y0002528Family CarboprostNeed a molecule you cannot find?
Custom synthesis of impurities, metabolites and labelled compounds, with the same characterisation level.